This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Orphazyme A/s. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovations of Claus Bornæs
Introduction
Claus Bornæs is a notable inventor based in Hellerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of glucocerebrosidase associated disorders. His innovative work has led to the development of a unique active pharmaceutical ingredient.
Latest Patents
Claus Bornæs holds a patent for Arimoclomol, which is an active pharmaceutical ingredient selected from N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the acid addition salts thereof. This invention is aimed at treating glucocerebrosidase associated disorders, showcasing his commitment to advancing medical treatments.
Career Highlights
Throughout his career, Claus has worked with several prominent companies, including Orphazyme A/S and Zevra Denmark A/S. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Claus has collaborated with notable professionals in his field, including Anders Mørkeberg Hinsby and Thomas Kirkegaard Jensen. These partnerships have further enhanced his innovative capabilities and have led to significant advancements in his research.
Conclusion
Claus Bornæs is a distinguished inventor whose work in pharmaceuticals has made a lasting impact on the treatment of glucocerebrosidase associated disorders. His innovative spirit and dedication to research continue to inspire advancements in medical science.